© 1992 Oxford University Press
other |
Association between expression of transforming growth factor-alpha and progression of hepatocellular foci to neoplasms
Department of Pathology and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill Chapel Hill, NC 27599-7295, USA
Hepatocarcinogenesis was initiated in rats with a single dose of either of two chemical mutagensbenzo[
]pyrene diolepoxide I and methyl(acetoxymethyl)nitrosamine-administered 15 h after hepatectomy.The development of hepatocellular foci and neoplasms was then promoted with dietary phenobarbital given for 45 or 62 weeks. Formalin-fixed tissue specimens that contained hepatic neoplasms and altered hepatocellular foci were screened for expression of the oncodevelopmental marker glutathione-S-transferase (placental form) (GSTP) and transforming growth factor-alpha (TGF-alpha) using immunnohistchemistry. AN (100%) hepatocellular carcinomas expressed both GSTP and TGF-alpha, as did most hepatocellular adenomas (>80%). However, quantitative stereologic analysis of treated and control livers revealed that GSTP-postive foci were 1030 times more frequent than TGF-alpha-positive foci. Foci with homogeneous expression of GSTP generally displayed heterogeneous expression of TGF-alpha with reaction product most prominent at their peripheries. Less frequently homogeneous TGF-alpha-positive foci were seen within GSTP-positive foci. The average volumes of those GSTP-positive foci that also expressed TGF-alpha were significantly greater than those of the entire sets of GSTP-positive foci. These results suggest that expression of TGF-alpha may distinguish a subset of Gm-positive foci that have a growth advantage and increased probability of progrrssion to neoplasia.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
K. Hufnagl, W. Parzefall, B. Marian, M. Kafer, K. Bukowska, R. Schulte-Hermann, and B. Grasl-Kraupp Role of transforming growth factor {alpha} and prostaglandins in preferential growth of preneoplastic rat hepatocytes Carcinogenesis, August 1, 2001; 22(8): 1247 - 1256. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kobayashi, M. Kusakabe, M. Okada, T. Sakairi, K. Goto, T. Tsuchiya, J. Sugimoto, F. Sano, and M. Mutai Immunohistochemical Localization of Transforming Growth Factor Alpha in Chemically Induced Rat Hepatocellular Carcinomas with Reference to Differentiation and Proliferation Toxicol Pathol, September 1, 2000; 28(5): 664 - 667. [Abstract] [PDF] |
||||
![]() |
M. Haag-Gronlund, R. Conolly, G. Scheu, L. Warngard, and R. Fransson-Steen Analysis of Rat Liver Foci Growth with a Quantitative Two-Cell Model after Treatment with 2,4,5,3',4'-Pentachlorobiphenyl Toxicol. Sci., September 1, 2000; 57(1): 32 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Moser, D. C. Wolf, and T. L. Goldsworthy Quantitative Relationship Between Transforming Growth Factor-Alpha and Hepatic Focal Phenotype and Progression in Female Mouse Liver Toxicol Pathol, May 1, 1997; 25(3): 275 - 283. [Abstract] [PDF] |
||||
![]() |
H. C. Pitot, Y. P Dragan, J. Teeguarden, S. Hsia, and H. Campbell Quantitation of Multistage Carcinogenesis in Rat Liver Toxicol Pathol, January 1, 1996; 24(1): 119 - 128. [Abstract] [PDF] |
||||


